tirzepatide uric acid Anyone using a GLP-1 notice reduced levels? Is tirzepatide (Mounjaro) safe to
Description
7.5 mg weeks 47
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial
The safest approach is to restart at the lowest dose and titrate up, though this may not be practical for frequent alternating
In most cases, these changes are thought to be related to weight loss, hormonal adjustments, improved insulin sensitivity, and changes in ovulation rather than a direct effect of the medication on the menstrual cycle
When someone says "I take 50 units of tirzepatide," that statement is meaningless without knowing the concentration
